The essential targets to inhibit sustained proliferation in cancer include the following signaling pathways: hypoxia-inducible factor-1 (HIF-1), NF-κBs, PI3K/AKT, insulin-like growth factor receptor (IGF-1R), cyclin-dependent kinase (CDKs), and estrogen receptor signaling [18]. This evidence concerns the gene IGF1R and cancer.